|
1
|
Jang JH, Choi MY, Lee SK, Kim S, Kim J,
Lee J, Jung SP, Choe JH, Kim JH, Kim JS, et al: Clinicopathologic
risk factors for the local recurrence of phyllodes tumors of the
breast. Ann Surg Oncol. 19:2612–2617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein L, Deapen D and Ross RK: The
descriptive epidemiology of malignant cystosarcoma phyllodes tumors
of the breast. Cancer. 71:3020–3024. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gradishar WJ, Anderson BO, Balassanian R,
Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A,
Giordano SH, et al: Breast Cancer, Version 1.2016. J Natl Compr
Canc Netw. 13:1475–1485. 2015.PubMed/NCBI
|
|
4
|
Birch JM, Alston RD, McNally RJ, Evans DG,
Kelsey AM, Harris M, Eden OB and Varley JM: Relative frequency and
morphology of cancers in carriers of germline TP53 mutations.
Oncogene. 20:4621–4628. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karczmarek-Borowska B, Bukala A,
Syrek-Kaplita K, Ksiazek M, Filipowska J and Gradalska-Lampart M: A
rare case of breast malignant phyllodes tumor with metastases to
the kidney: Case report. Medicine (Baltimore). 94:e13122015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mituś J, Reinfuss M, Mituś JW, Jakubowicz
J, Blecharz P, Wysocki WM and Skotnicki P: Malignant phyllodes
tumor of the breast: Treatment and prognosis. Breast J. 20:639–644.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reinfuss M, Mituś J, Smolak K and Stelmach
A: Malignant phyllodes tumours of the breast. A clinical and
pathological analysis of 55 cases. Eur J Cancer. 29A:1252–1256.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sedgwick EL, Ebuoma L, Hamame A, Phalak K,
Ruiz-Flores L, Ortiz-Perez T and Sepulveda KA: BI-RADS update for
breast cancer caregivers. Breast Cancer Res Treat. 150:243–254.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma XB, Zheng Y, Yuan HP, Jiang J and Wang
YP: CD43 expression in diffuse large B-cell lymphoma, not otherwise
specified: CD43 is a marker of adverse prognosis. Hum Pathol.
46:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: WHO classification of tumours of the breast.
IARC WHO Classification of Tumours. 4:(4th). IARC Press. (Lyon).
2012.
|
|
12
|
Wu DI, Zhang H, Guo L, Yan XU and Fan Z:
Invasive ductal carcinoma within borderline phyllodes tumor with
lymph node metastases: A case report and review of the literature.
Oncol Lett. 11:2502–2506. 2016.PubMed/NCBI
|
|
13
|
Bellocq JP and Magro G: Fibroepithelial
tumours (Chapter 1 - Tumours of the Breast). Pathology and Genetics
- Tumours of the Breast and Female Genital Organs (World Health
Organization Classification of Tumours). Tavassoli FA and Devilee
P: (5th). IARC Press. (Lyon, France). 99–103. 2003.
|
|
14
|
Barth RJ Jr, Wells WA, Mitchell SE and
Cole BF: A prospective, multi-institutional study of adjuvant
radiotherapy after resection of malignant phyllodes tumors. Ann
Surg Oncol. 16:2288–2294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aguiar Bujanda D, Rivero Vera JC, Cabrera
Suárez MA, Aguiar Morales J, Christol R, Bohn Sarmiento U,
Domínguez Cabrera C and Le Bouc Y: Hypoglycemic coma secondary to
big insulin-like growth factor II secretion by a giant phyllodes
tumor of the breast. Breast J. 13:189–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kataoka T, Haruta R, Goto T, Sugino K,
Asahara T, Dohi K, Kaneco M, Arihiro K and Nomura S: Malignant
phyllodes tumor of the breast with hypoglycemia: Report of a case.
Jpn J Clin Oncol. 28:276–280. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rowe JJ and Prayson RA: Metastatic
malignant phyllodes tumor involving the cerebellum. J Clin
Neurosci. 22:226–227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hlavin ML, Kaminski HJ, Cohen M,
Abdul-Karim FW and Ganz E: Central nervous system complications of
cystosarcoma phyllodes. Cancer. 72:126–130. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Al-Zoubaidi M, Qiu S, Bonnen M, Bonnen M,
Joyner M, Roehl K, Silva C and Chao C: Malignant phyllodes tumor of
the breast: A case report. Open Breast Cancer J. 3:45–48. 2011.
View Article : Google Scholar
|
|
20
|
Salvadori B, Cusumano F, Del Bo R,
Delledonne V, Grassi M, Rovini D, Saccozzi R, Andreola S and
Clemente C: Surgical treatment of phyllodes tumors of the breast.
Cancer. 63:2532–2536. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barth RJ: Histologic features predict
local recurrence after breast conserving therapy of phyllodes
tumors. Breast Cancer Res Treat. 57:291–295. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan SA and Badve S: Phyllodes tumors of
the breast. Curr Treat Options Oncol. 2:139–147. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Belkacémi Y, Bousquet G, Marsiglia H,
Ray-Coquard I, Magné N, Malard Y, Lacroix M, Gutierrez C, Senkus E,
Christie D, et al: Phyllodes tumor of the breast. Int J Radiat
Oncol Biol Phys. 70:492–500. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khosravi-Shahi P: Management of non
metastatic phyllodes tumors of the breast: Review of the
literature. Surg Oncol. 20:e143–e148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kraemer B, Hoffmann J, Roehm C, Gall C,
Wallwiener D and Krainick-Strobel U: Cystosarcoma phyllodes of the
breast: A rare diagnosis: Case studies and review of literature.
Arch Gynecol Obstet. 276:649–653. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pezner RD, Schultheiss TE and Paz IB:
Malignant phyllodes tumor of the breast: Local control rates with
surgery alone. Int J Radiat Oncol Biol Phys. 71:710–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kapiris I, Nasir N, A'Hern R, Healy V and
Gui GP: Outcome and predictive factors of local recurrence and
distant metastases following primary surgical treatment of
high-grade malignant phyllodes tumors of the breast. Eur J Surg
Oncol. 27:723–730. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burton GV, Hart LL, Leight GS Jr, Iglehart
JD, McCarty KS Jr and Cox EB: Cystosarcoma phyllodes: Effective
therapy with cisplatin and etoposide chemotherapy. Cancer.
63:2088–2092. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pacioles T, Seth R, Orellana C, John I,
Panuganty V and Dhaliwal R: Malignant phyllodes tumor of the breast
presenting with hypoglycemia: A case report and literature review.
Cancer Manag Res. 6:467–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hawkins RE, Schofield JB, Wiltshaw E,
Fisher C and McKinna JA: Ifosfamide is an active drug for
chemotherapy of metastatic cystosarcoma phyllodes. Cancer.
69:2271–2275. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tse GM, Lee CS, Kung FY, Scolyer RA, Law
BK, Lau TS and Putti TC: Hormonal receptors expression in
epithelial cells of mammary phyllodes tumors correlates with
pathologic grade of the tumor: A multicenter study of 143 cases. Am
J Clin Pathol. 118:522–526. 2002. View Article : Google Scholar : PubMed/NCBI
|
